Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye drops

Journal of Drug Delivery Science and Technology

Volumn 36, Issue , 2016, Pages 168-174

  Lim, Chaemin ^a   Kim, Da won ^a   Sim, Taehoon ^a   Hoang, Ngoc Ha ^a   Lee, Jun Won ^a   Lee, Eun Seong ^b   Youn, Yu Seok ^c   Oh, Kyung Teak ^a  

^a Chung Ang University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Emulsion morphology; Lutein; Nanoemulsion; Nanosize; Ophthalmic drug delivery system; Pseudo ternary phase diagram

Indexed keywords

ALCOHOL; CROTON OIL; EYE DROPS; MYRISTIC ACID ISOPROPYL ESTER; POLYSORBATE 80; SOYBEAN OIL; STARCH; TRIACETIN; XANTHOPHYLL;

AGE RELATED MACULAR DEGENERATION; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; NANOEMULSION; PARTICLE SIZE; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; TURBIDITY;

EID: 84993978558     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2016.10.009     Document Type: Article

References (40)

1. [1] Beatty, S., Murray, I.J., Henson, D.B., Carden, D., Koh, H., Boulton, M.E., Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Investig. Ophthalmol. Vis. Sci. 42:2 (2001), 439–446.
2. [2] Bone, R.A., Landrum, J.T., Mayne, S.T., Gomez, C.M., Tibor, S.E., Twaroska, E.E., Macular pigment in donor eyes with and without AMD: a case-control study. Investig. Ophthalmol. Vis. Sci. 42:1 (2001), 235–240.
3. [3] Abdel-Aal, E.M., Akhtar, H., Zaheer, K., Ali, R., Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health. Nutrients 5:4 (2013), 1169–1185.
4. [4] Bressler, N.M., Age-related macular degeneration is the leading cause of blindness. Jama 291:15 (2004), 1900–1901.
5. [5] Gale, C.R., Hall, N.F., Phillips, D.I., Martyn, C.N., Lutein and zeaxanthin status and risk of age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 44:6 (2003), 2461–2465.
6. [6] Granado, F., Olmedilla, B., Blanco, I., Nutritional and clinical relevance of lutein in human health. Br. J. Nutr. 90:3 (2003), 487–502.
7. [7] Johnson, E.J., A biological role of lutein. Food Rev. Int. 20:1 (2004), 1–16.
8. [8] Landrum, J.T., Bone, R.A., Joa, H., Kilburn, M.D., Moore, L.L., Sprague, K.E., A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp. Eye Res. 65:1 (1997), 57–62.
9. [9] Tetko, I.V., Tanchuk, V.Y., Kasheva, T.N., Villa, A.E.P., Estimation of aqueous solubility of chemical compounds using e-state indices. J. Chem. Inf. Comput. Sci. 41:6 (2001), 1488–1493.
10. [10] Shanmugam, S., Baskaran, R., Balakrishnan, P., Thapa, P., Yong, C.S., Yoo, B.K., Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. Eur. J. Pharm. Biopharm. 79:2 (2011), 250–257.
11. [11] Ammar, H.O., Salama, H.A., Ghorab, M., Mahmoud, A.A., Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech. 10:3 (2009), 808–819.
12. [12] Yoo, J.H., Shanmugam, S., Thapa, P., Lee, E.S., Balakrishnan, P., Baskaran, R., Yoon, S.K., Choi, H.G., Yong, C.S., Yoo, B.K., Han, K., Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch. Pharm. Res. 33:3 (2010), 417–426.
13. [13] Gärtner, C., West, C., Tijburg, L., Potential of vegetable processing to increase the delivery of carotenoids to man. Journal international de vitaminologie et de nutrition Int. J. Vitam. Nutr. Res. Int. Z. Vitam Ernahrungsforschung 68:6 (1997), 366–370.
14. [14] Le Bourlais, C., Acar, L., Zia, H., Sado, P.A., Needham, T., Leverge, R., Ophthalmic drug delivery systems—recent advances. Prog. Retin. Eye Res. 17:1 (1998), 33–58.
15. [15] Yamaguchi, M., Yasueda, S., Isowaki, A., Yamamoto, M., Kimura, M., Inada, K., Ohtori, A., Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Int. J. Pharm. 301:1–2 (2005), 121–128.
16. [16] Kaur, I.P., Kakkar, S., Nanotherapy for posterior eye diseases. J. Control Release 193 (2014), 100–112.
17. [17] Alany, R.G., Rades, T., Nicoll, J., Tucker, I.G., Davies, N.M., W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. J. Control. Release 111:1–2 (2006), 145–152.
18. [18] Almeida, H., Amaral, M.H., Lobao, P., Silva, A.C., Loboa, J.M., Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations. J. Pharm. Pharm. Sci. 17:3 (2014), 278–293.
19. [19] Vandamme, T.F., Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog. Retin. Eye Res. 21:1 (2002), 15–34.
20. [20] Pignatello, R., Carbone, C., Puglia, C., Offerta, A., Bonina, F.P., Puglisi, G., Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity. Ther. Deliv. 6:11 (2015), 1297–1318.
21. [21] Beg, S., Swain, S., Singh, H.P., Patra, C.N., Rao, M.E.B., Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech. 13:4 (2012), 1416–1427.
22. [22] Boonme, P., Krauel, K., Graf, A., Rades, T., Junyaprasert, V.B., Characterization of microemulsion structures in the pseudoternary phase diagram of isopropyl palmitate/water/Brij 97:1-butanol. AAPS PharmSciTech., 7(2), 2006, E45.
23. [23] Li, N., Zhuang, C., Wang, M., Sun, X., Nie, S., Pan, W., Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int. J. Pharm. 379:1 (2009), 131–138.
24. [24] Gupta, H., Aqil, M., Khar, R.K., Ali, A., Bhatnagar, A., Mittal, G., Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomed. Nanotechnol. Biol. Med. 6:2 (2010), 324–333.
25. [25] Buyukozturk, F., Benneyan, J.C., Carrier, R.L., Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J. Control. Release 142:1 (2010), 22–30.
26. [26] Constantinides, P.P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12:11 (1995), 1561–1572.
27. [27] Szumala, P., Structure of microemulsion formulated with monoacylglycerols in the presence of polyols and ethanol. J. Surfactants Deterg. 18:1 (2015), 97–106.
28. [28] Conquet, P., Durand, G., Laillier, J., Plazonnet, B., Evaluation of ocular irritation in the rabbit: objective versus subjective assessment. Toxicol. Appl. Pharmacol. 39:1 (1977), 129–139.
29. [29] Hughes, W. Jr., The tolerance of rabbit cornea for various chemical substances. Bull. Johns Hopkins Hosp. 82:2 (1948), 338–349.
30. [30] Shafiq, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., Khar, R.K., Ali, M., Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech. 8:2 (2007), E12–E17.
31. [31] Nakarani, M., Patel, P., Patel, J., Patel, P., Murthy, R.S., Vaghani, S.S., Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation. Sci. Pharm. 78:2 (2010), 345–361.
32. [32] Calvo, P., Sánchez, A., Martínez, J., López, M.I., Calonge, M., Pastor, J.C., Alonso, M.J., Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharm. Res. 13:2 (1996), 311–315.
33. [33] Arunkumar, R., Prashanth, K.V.H., Baskaran, V., Promising interaction between nanoencapsulated lutein with low molecular weight chitosan: characterization and bioavailability of lutein in vitro and in vivo. Food Chem. 141:1 (2013), 327–337.
34. [34] Hecker, E., Phorbol esters from croton oil. Chemical nature and biological activities. Naturwissenschaften 54:11 (1967), 282–284.
35. [35] Hegde, R.R., Verma, A., Ghosh, A., Microemulsion: new insights into the ocular drug delivery. ISRN Pharm., 2013, 2013.
36. [36] Azeem, A., Rizwan, M., Ahmad, F.J., Iqbal, Z., Khar, R.K., Aqil, M., Talegaonkar, S., Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. 10:1 (2009), 69–76.
37. [37] Gupta, A.K., Madan, S., Majumdar, D.K., Maitra, A., Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. Int. J. Pharm. 209:1–2 (2000), 1–14.
38. [38] Morsi, N.M., Mohamed, M.I., Refai, H., El Sorogy, H.M., Nanoemulsion as a Novel Ophthalmic Delivery System for Acetazolamide. 2014 10.
39. [39] Nagarwal, R.C., Kant, S., Singh, P.N., Maiti, P., Pandit, J.K., Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J. Control. Release 136:1 (2009), 2–13.
40. [40] Leong, T.S.H., Wooster, T.J., Kentish, S.E., Ashokkumar, M., Minimising oil droplet size using ultrasonic emulsification. Ultrason. Sonochem. 16:6 (2009), 721–727.